Breaking News Instant updates and real-time market news.

ZGNX

Zogenix

$56.20

-0.15 (-0.27%)

17:14
08/06/18
08/06
17:14
08/06/18
17:14

Zogenix files to sell 6M shares of common stock

BofA Merrill Lynch, Leerink Partners and Stifel are acting as joint book-running managers for the offering. Mizuho Securities and JMP Securities are acting as co-lead managers for the offering, and LifeSci Capital is acting as co-manager for the offering.

  • 06

    Aug

ZGNX Zogenix
$56.20

-0.15 (-0.27%)

04/20/18
MZHO
04/20/18
NO CHANGE
Target $51
MZHO
Buy
Mizuho reiterates Buy on Zogenix after GW Pharmaceuticals FDA panel
After an FDA panel unanimously voted in favor of approving GW Pharmaceuticals' (GWPH) Epidiolex, Mizuho analyst Difei Yang reiterates a Buy rating on Zogenix (ZGNX) with a $51 price target. Superior efficacy of Zogenix competitor ZX008, as demonstrated in the most recent Phase 3 results, means that FDA approval would be highly likely assuming positive data from the second Phase 3 study, expected in June, Yang tells investors in a research note. She believes readouts on the study could be an important share moving event and are "highly likely" to be positive.
07/12/18
MZHO
07/12/18
NO CHANGE
Target $69
MZHO
Buy
Zogenix price target raised to $69 from $51 at Mizuho
Mizuho analyst Difei Yang raised her view on the probability of success for ZX008 in Dravet syndrome to 100% after the company reported positive results from its second phase 3 study of the drug. Yang, who called the study "the last roadblock" prior to submitting regulatory applications in the U.S. and Europe for ZX008 in Dravet, increased her price target on Zogenix to $69 and keeps a Buy rating on the shares.
07/13/18
LEER
07/13/18
NO CHANGE
Target $92
LEER
Outperform
Zogenix price target raised to $92 from $52 at Leerink
Leerink analyst Geoffrey Porges raised his price target for Zogenix to $92 from $52 after the company reports topline data from its second Dravet phase 3 study yesterday, stating that the data appear to represent a "best case scenario" given they approximate study one's strong efficacy and show clean cardiac safety. Porges, who thinks yesterday's 21% advance in the shares was a "reasonable reflection of the confirmation of the drug's profile," maintains an Outperform rating on Zogenix shares.
07/30/18
EAMC
07/30/18
NO CHANGE
Target $66
EAMC
Buy
Zogenix price target raised to $66 from $56 at Empire
Empire analyst Dr. Cathy Reese raised Buy rated Zogenix's price target to $66 from $56 citing a reduction in clinical development risk following Fintepla's second confirmatory Phase III study. Reese said this was the final large Fintepla clinical hurdle that needed to be cleared so Zogenix could file its U.S. and E.U. submissions for this drug to be considered as a therapy for Dravet syndrome patients.

TODAY'S FREE FLY STORIES

GG

Goldcorp

$10.70

-0.47 (-4.21%)

, NEM

Newmont Mining

$34.52

0.2 (0.58%)

14:25
03/22/19
03/22
14:25
03/22/19
14:25
Hot Stocks
BCI says will exercise holder rights in voting against Goldcorp-Newmont merger »

British Columbia…

GG

Goldcorp

$10.70

-0.47 (-4.21%)

NEM

Newmont Mining

$34.52

0.2 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Apr

FCAU

Fiat Chrysler

$14.58

-0.43 (-2.86%)

14:25
03/22/19
03/22
14:25
03/22/19
14:25
Options
Fiat Chrysler call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LXRX

Lexicon

$7.51

-0.45 (-5.65%)

, SNY

Sanofi

$44.34

-1.07 (-2.36%)

14:23
03/22/19
03/22
14:23
03/22/19
14:23
Hot Stocks
Lexicon to resume trading at 2:45 pm ET »

Lexicon (LXRX) shares are…

LXRX

Lexicon

$7.51

-0.45 (-5.65%)

SNY

Sanofi

$44.34

-1.07 (-2.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

  • 25

    Apr

  • 28

    Apr

PDLB

PDL Community Bancorp

$13.63

-0.01 (-0.07%)

14:21
03/22/19
03/22
14:21
03/22/19
14:21
Hot Stocks
PDL Community Bancorp to repurchase up to 923,151 common shares »

PDL Community Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
03/22/19
03/22
14:17
03/22/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNI

Scripps Networks

$0.00

(0.00%)

, LXRX

Lexicon

$7.51

-0.45 (-5.65%)

14:16
03/22/19
03/22
14:16
03/22/19
14:16
Hot Stocks
Sanofi says FDA issues CRL for Zynquista »

The U.S. Food and Drug…

SNI

Scripps Networks

$0.00

(0.00%)

LXRX

Lexicon

$7.51

-0.45 (-5.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

  • 25

    Apr

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
03/22/19
03/22
14:16
03/22/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMN

AMN Healthcare

$48.35

-0.895 (-1.82%)

14:15
03/22/19
03/22
14:15
03/22/19
14:15
Conference/Events
AMN Healthcare management to meet with Benchmark »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 27

    Mar

  • 17

    Apr

W

Wayfair

$159.46

-11.73 (-6.85%)

14:15
03/22/19
03/22
14:15
03/22/19
14:15
Options
Wayfair put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:15
03/22/19
03/22
14:15
03/22/19
14:15
General news
U.S. Treasury reported a -$234 B budget deficit for February »

U.S. Treasury reported a…

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

, SPX

S&P 500

$0.00

(0.00%)

14:13
03/22/19
03/22
14:13
03/22/19
14:13
Periodicals
Trump to withdraw new North Korea-related sanctions, CNBC says »

U.S. President Donald…

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$279.71

-4.92 (-1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMED

Amedisys

$123.24

-2.89 (-2.29%)

14:11
03/22/19
03/22
14:11
03/22/19
14:11
Conference/Events
Amedisys management to meet with Wiliam Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

  • 29

    Mar

  • 02

    Apr

  • 03

    Apr

NEM

Newmont Mining

$34.57

0.25 (0.73%)

, GG

Goldcorp

$10.71

-0.46 (-4.12%)

14:10
03/22/19
03/22
14:10
03/22/19
14:10
Periodicals
VanEck wants Newmont to renegotiate terms of Goldcorp deal, WSJ reports »

Joe Foster, who runs one…

NEM

Newmont Mining

$34.57

0.25 (0.73%)

GG

Goldcorp

$10.71

-0.46 (-4.12%)

GOLD

Barrick Gold

$13.48

0.2 (1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Apr

14:10
03/22/19
03/22
14:10
03/22/19
14:10
General news
U.S. Treasury budget preview: »

U.S. Treasury budget…

AGO

Assured Guaranty

$45.19

-0.14 (-0.31%)

14:07
03/22/19
03/22
14:07
03/22/19
14:07
Conference/Events
Assured Guaranty management to meet with MKM Partners »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

  • 29

    Mar

  • 16

    Apr

  • 17

    Apr

14:03
03/22/19
03/22
14:03
03/22/19
14:03
General news
Treasury Budget data reported »

February Treasury Budget…

QCOM

Qualcomm

$57.16

-0.6 (-1.04%)

14:00
03/22/19
03/22
14:00
03/22/19
14:00
Options
Size spread in Qualcomm as shares slip »

Size spread in Qualcomm…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

EVER

EverQuote

$7.80

-0.1 (-1.27%)

13:59
03/22/19
03/22
13:59
03/22/19
13:59
Conference/Events
EverQuote management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 28

    Mar

RYTM

Rhythm Pharmaceuticals

$30.01

-0.64 (-2.09%)

13:59
03/22/19
03/22
13:59
03/22/19
13:59
Conference/Events
Rhythm Pharmaceuticals management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

TWOU

2U

$66.19

-2.92 (-4.23%)

13:57
03/22/19
03/22
13:57
03/22/19
13:57
Conference/Events
2U management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

GLW

Corning

$33.89

-0.91 (-2.61%)

13:55
03/22/19
03/22
13:55
03/22/19
13:55
Options
Corning put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATEC

Alphatec

$2.60

-0.12 (-4.41%)

13:52
03/22/19
03/22
13:52
03/22/19
13:52
Conference/Events
Alphatec management to meet with Lake Street »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

TLRA

Telaria

$6.16

-0.25 (-3.90%)

13:52
03/22/19
03/22
13:52
03/22/19
13:52
Conference/Events
Telaria management to meet with Lake Street »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

SRDX

Surmodics

$42.26

-3.67 (-7.99%)

13:51
03/22/19
03/22
13:51
03/22/19
13:51
Conference/Events
Surmodics management to meet with Lake Street »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

TPR

Tapestry

$31.23

-0.72 (-2.25%)

13:49
03/22/19
03/22
13:49
03/22/19
13:49
Options
Tapestry option volume 4x normal as shares test multiyear lows »

Tapestry option volume 4x…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.